The effect of transdermal testosterone gel300mcg daily on cognitive performance in older postmenopausal women: a placebo controlled trial over 26 weeks.
Phase of Trial: Phase II
Latest Information Update: 08 Jun 2016
At a glance
- Drugs Testosterone (Primary)
- Indications Cognition disorders
- Focus Therapeutic Use
- 29 Jan 2014 Status changed from recruiting to completed as reported by Australian New Zealand Clinical Trials Registry record.
- 14 Jul 2010 Status changed from not yet recruiting to recruiting, according to a BioSante Pharmaceuticals media release.
- 18 Nov 2009 New trial record